• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

儿童人群中，与鼻咽样本逆转录-聚合酶链反应检测相比，Panbio 严重急性呼吸综合征冠状病毒 2 抗原快速检测的诊断准确性。

Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population.

机构信息

Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Fundación para la Investigación Biomédica Hospital 12 de Octubre, Madrid, Spain.

Pediatric Research and Clinical Trials Unit (UPIC), Instituto de Investigación Sanitaria Hospital 12 de Octubre (IMAS12), Fundación para la Investigación Biomédica Hospital 12 de Octubre, Madrid, Spain.

出版信息

J Pediatr. 2021 May;232:287-289.e4. doi: 10.1016/j.jpeds.2021.01.027. Epub 2021 Jan 21.

DOI:10.1016/j.jpeds.2021.01.027
PMID:33484697
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7826137/
Abstract

We conducted a multicenter clinical validity study of the Panbio coronavirus disease 2019 Antigen Rapid Test of nasopharyngeal samples in pediatric patients with coronavirus disease 2019-compatible symptoms of ≤5 days of evolution. Our study showed limited accuracy in nasopharyngeal antigen testing: overall sensitivity was 45.4%, and 99.8% of specificity, positive-predictive value was 92.5%.

摘要

我们对 Panbio 新型冠状病毒病 2019 抗原快速检测试剂盒（鼻咽拭子）进行了一项多中心临床有效性研究，该检测用于检测发病 5 天以内的具有新型冠状病毒病 2019 症状的儿科患者的鼻咽样本。我们的研究显示，鼻咽抗原检测的准确性有限：总敏感度为 45.4%，特异性为 99.8%，阳性预测值为 92.5%。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/7826137/316f8d821169/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/7826137/6565a65760a4/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/7826137/316f8d821169/fx2_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/7826137/6565a65760a4/fx1_lrg.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4ba5/7826137/316f8d821169/fx2_lrg.jpg

相似文献

1
Diagnostic Accuracy of the Panbio Severe Acute Respiratory Syndrome Coronavirus 2 Antigen Rapid Test Compared with Reverse-Transcriptase Polymerase Chain Reaction Testing of Nasopharyngeal Samples in the Pediatric Population.儿童人群中，与鼻咽样本逆转录-聚合酶链反应检测相比，Panbio 严重急性呼吸综合征冠状病毒 2 抗原快速检测的诊断准确性。
J Pediatr. 2021 May;232:287-289.e4. doi: 10.1016/j.jpeds.2021.01.027. Epub 2021 Jan 21.
2
Clinical Evaluation of the Accuracy of the Panbio™ COVID-19/Flu A&B Rapid Panel: A Combination Antigen Rapid Diagnostic Test for the Omicron Variant and Influenza A Virus.Panbio™ COVID-19/Flu A&B 快速检测试剂盒的临床评估：一种针对奥密克戎变异株和甲型流感病毒的联合抗原快速诊断检测试剂。
Viral Immunol. 2024 Aug;37(6):317-321. doi: 10.1089/vim.2024.0039. Epub 2024 Jul 13.
3
Evaluation of clinical utility of novel coronavirus antigen detection reagent, Espline® SARS-CoV-2.评估新型冠状病毒抗原检测试剂 Espline® SARS-CoV-2 的临床实用性。
J Infect Chemother. 2021 Feb;27(2):319-322. doi: 10.1016/j.jiac.2020.11.015. Epub 2020 Dec 23.
4
Field evaluation of COVID-19 antigen tests versus RNA based detection: Potential lower sensitivity compensated by immediate results, technical simplicity, and low cost.现场评估 COVID-19 抗原检测与基于 RNA 的检测：即时结果、技术简单性和低成本弥补了潜在的低灵敏度。
J Med Virol. 2021 Jul;93(7):4405-4410. doi: 10.1002/jmv.26985. Epub 2021 Apr 8.
5
Immunochromatographic test for the detection of SARS-CoV-2 in saliva.免疫层析试验检测唾液中的 SARS-CoV-2。
J Infect Chemother. 2021 Feb;27(2):384-386. doi: 10.1016/j.jiac.2020.11.016. Epub 2020 Dec 23.
6
Rapid Implementation of Severe Acute Respiratory Syndrome Coronavirus 2 Emergency Use Authorization RT-PCR Testing and Experience at an Academic Medical Institution.严重急性呼吸综合征冠状病毒 2 紧急使用授权 RT-PCR 检测的快速实施及学术医疗机构的经验。
J Mol Diagn. 2021 Feb;23(2):149-158. doi: 10.1016/j.jmoldx.2020.10.019. Epub 2020 Dec 5.
7
Clinical validation of quantitative SARS-CoV-2 antigen assays to estimate SARS-CoV-2 viral loads in nasopharyngeal swabs.临床验证定量 SARS-CoV-2 抗原检测法以估计鼻咽拭子中的 SARS-CoV-2 病毒载量。
J Infect Chemother. 2021 Apr;27(4):613-616. doi: 10.1016/j.jiac.2020.11.021. Epub 2020 Dec 3.
8
Comparison between Nasal and Nasopharyngeal Swabs for SARS-CoV-2 Rapid Antigen Detection in an Asymptomatic Population, and Direct Confirmation by RT-PCR from the Residual Buffer.鼻拭子和咽拭子在无症状人群中用于 SARS-CoV-2 快速抗原检测的比较，以及从剩余缓冲液中用 RT-PCR 直接确认。
Microbiol Spectr. 2022 Feb 23;10(1):e0245521. doi: 10.1128/spectrum.02455-21. Epub 2022 Feb 16.
9
Clinical assessment of the Roche SARS-CoV-2 rapid antigen test.罗氏 SARS-CoV-2 快速抗原检测的临床评估。
Diagnosis (Berl). 2021 Jan 18;8(3):322-326. doi: 10.1515/dx-2020-0154. Print 2021 Aug 26.
10
Real-life evaluation of a COVID-19 rapid antigen detection test in hospitalized children.在院儿童中 COVID-19 快速抗原检测的真实世界评估。
J Med Virol. 2021 Oct;93(10):6040-6044. doi: 10.1002/jmv.27149. Epub 2021 Jul 1.

引用本文的文献

1
Clinical Evaluation of the Healgen Rapid COVID-19 Antigen Test as a Point-of-Care Diagnostic Tool.Healgen新冠病毒快速抗原检测作为即时诊断工具的临床评估
Immun Inflamm Dis. 2025 Jul;13(7):e70228. doi: 10.1002/iid3.70228.
2
Application of a SARS-CoV-2 Antigen Rapid Immunoassay Based on Active Microfluidic Technology in a Setting of Children and Young Adults.基于主动微流控技术的 SARS-CoV-2 抗原快速免疫测定在儿童和青年人群中的应用。
Viruses. 2023 Dec 26;16(1):41. doi: 10.3390/v16010041.
3
The sensitivity and specificity of Abbott Panbio™ COVID 19 Ag Rapid test in the context of four SARS-CoV-2 variants.

本文引用的文献

1
Test sensitivity is secondary to frequency and turnaround time for COVID-19 screening.新冠病毒筛查时，检测敏感性次于检测频率和周转时间。
Sci Adv. 2021 Jan 1;7(1). doi: 10.1126/sciadv.abd5393. Print 2021 Jan.
2
Field evaluation of a rapid antigen test (Panbio™ COVID-19 Ag Rapid Test Device) for COVID-19 diagnosis in primary healthcare centres.基层医疗机构中一种用于 COVID-19 诊断的快速抗原检测试剂（Panbio™ COVID-19 Ag Rapid Test Device）的现场评估。
Clin Microbiol Infect. 2021 Mar;27(3):472.e7-472.e10. doi: 10.1016/j.cmi.2020.11.004. Epub 2020 Nov 13.
3
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms.
在四种严重急性呼吸综合征冠状病毒2（SARS-CoV-2）变体背景下，雅培Panbio™新冠病毒抗原快速检测的敏感性和特异性
Heliyon. 2023 Dec 9;10(1):e23475. doi: 10.1016/j.heliyon.2023.e23475. eCollection 2024 Jan 15.
4
Diagnostic accuracy of Panbio™ rapid antigen test for SARS-CoV-2 in paediatric population.Panbio™ 快速抗原检测试剂盒用于儿童人群中 SARS-CoV-2 的诊断准确性。
BMC Pediatr. 2023 Aug 29;23(1):433. doi: 10.1186/s12887-023-04201-z.
5
The Infectious Diseases Society of America Guidelines on the Diagnosis of COVID-19: Antigen Testing (January 2023).美国传染病学会关于 COVID-19 诊断的指南：抗原检测（2023 年 1 月）。
Clin Infect Dis. 2024 Jun 27;78(7):e350-e384. doi: 10.1093/cid/ciad032.
6
Diagnostic accuracy of the Panbio COVID-19 antigen rapid test device for SARS-CoV-2 detection in Kenya, 2021: A field evaluation.2021 年肯尼亚 Panbio COVID-19 抗原快速检测设备对 SARS-CoV-2 检测的诊断准确性：现场评估。
PLoS One. 2023 Jan 25;18(1):e0277657. doi: 10.1371/journal.pone.0277657. eCollection 2023.
7
Differential clinical characteristics and performance of home antigen tests between parents and children after household transmission of SARS-CoV-2 during the Omicron variant pandemic.奥密克戎变异株流行期间家庭传播后父母与儿童的家用抗原检测的临床特征和性能差异。
Int J Infect Dis. 2023 Mar;128:301-306. doi: 10.1016/j.ijid.2023.01.014. Epub 2023 Jan 13.
8
Diagnostic accuracy of SARS-CoV-2 antigen test in the pediatric population: A systematic review and meta-analysis.儿童人群中 SARS-CoV-2 抗原检测的诊断准确性：系统评价和荟萃分析。
Pediatr Neonatol. 2023 May;64(3):247-255. doi: 10.1016/j.pedneo.2022.07.012. Epub 2022 Oct 25.
9
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) antigen detection in the Emergency Department: data from a pediatric cohort during the fourth COVID-19 wave in Italy.严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）在急诊科的抗原检测：意大利第四波 COVID-19 期间儿科队列的数据。
Ital J Pediatr. 2022 Aug 26;48(1):155. doi: 10.1186/s13052-022-01343-1.
10
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.用于 SARS-CoV-2 感染诊断的快速、即时抗原检测。
Cochrane Database Syst Rev. 2022 Jul 22;7(7):CD013705. doi: 10.1002/14651858.CD013705.pub3.
Panbio 抗原快速检测在症状出现后 7 天内对诊断 SARS-CoV-2 感染是可靠的。
J Clin Virol. 2020 Dec;133:104659. doi: 10.1016/j.jcv.2020.104659. Epub 2020 Oct 16.
4
Duration of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infectivity: When Is It Safe to Discontinue Isolation?严重急性呼吸综合征冠状病毒 2 （SARS-CoV-2）感染持续时间：何时可以安全解除隔离？
Clin Infect Dis. 2021 Apr 26;72(8):1467-1474. doi: 10.1093/cid/ciaa1249.
5
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Upper Respiratory Tract of Children and Adults With Early Acute Coronavirus Disease 2019 (COVID-19).2019年早期急性冠状病毒病（COVID-19）儿童和成人上呼吸道中的严重急性呼吸综合征冠状病毒2（SARS-CoV-2）病毒载量
Clin Infect Dis. 2021 Jul 1;73(1):148-150. doi: 10.1093/cid/ciaa1157.
6
Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples.评价一种新型基于抗原的快速检测试验，用于呼吸道样本中 SARS-CoV-2 的诊断。
Int J Infect Dis. 2020 Oct;99:328-333. doi: 10.1016/j.ijid.2020.05.098. Epub 2020 Jun 1.